These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 8332901)

  • 1. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.
    Rawlings DJ; Saffran DC; Tsukada S; Largaespada DA; Grimaldi JC; Cohen L; Mohr RN; Bazan JF; Howard M; Copeland NG
    Science; 1993 Jul; 261(5119):358-61. PubMed ID: 8332901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
    Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
    Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
    de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
    Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.
    Cancro MP; Sah AP; Levy SL; Allman DM; Schmidt MR; Woodland RT
    Int Immunol; 2001 Dec; 13(12):1501-14. PubMed ID: 11717191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity.
    Fukuda M; Kojima T; Kabayama H; Mikoshiba K
    J Biol Chem; 1996 Nov; 271(48):30303-6. PubMed ID: 8939985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation.
    Vinuesa CG; Sunners Y; Pongracz J; Ball J; Toellner KM; Taylor D; MacLennan IC; Cook MC
    Eur J Immunol; 2001 May; 31(5):1340-50. PubMed ID: 11465091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
    Petro JB; Rahman SM; Ballard DW; Khan WN
    J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
    Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
    Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction.
    Santos-Argumedo L; Lund FE; Heath AW; Solvason N; Wu WW; Grimaldi JC; Parkhouse RM; Howard M
    Int Immunol; 1995 Feb; 7(2):163-70. PubMed ID: 7734414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease.
    Webb CF; Yamashita Y; Ayers N; Evetts S; Paulin Y; Conley ME; Smith EA
    J Immunol; 2000 Dec; 165(12):6956-65. PubMed ID: 11120822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.
    Dingjan GM; Maas A; Nawijn MC; Smit L; Voerman JS; Grosveld F; Hendriks RW
    EMBO J; 1998 Sep; 17(18):5309-20. PubMed ID: 9736610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.
    Anderson JS; Teutsch M; Dong Z; Wortis HH
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10966-71. PubMed ID: 8855292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. xid affects events leading to B cell cycle entry.
    Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
    J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Bruton's tyrosine kinase in B cell development.
    Maas A; Hendriks RW
    Dev Immunol; 2001; 8(3-4):171-81. PubMed ID: 11785667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
    Mizuno T; Rothstein TL
    J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new molecular genetic diagnosis of the Btk(xid) mice.
    Takagi Y; Masui N; Yasuda M; Ono S
    Exp Anim; 2007 Jan; 56(1):63-6. PubMed ID: 17283893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
    Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
    J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
    Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
    J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation.
    Bajpai UD; Zhang K; Teutsch M; Sen R; Wortis HH
    J Exp Med; 2000 May; 191(10):1735-44. PubMed ID: 10811866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.